BioWorld - Friday, December 26, 2025 To read the full story, subscribe or sign in. US pediatric voucher making moves in Congress Dec. 2, 2025 By Mari Serebrov The next stop on the comeback tour for the U.S. FDA’s Rare Pediatric Disease Priority Review Voucher program is the Senate, after the House unanimously passed the Mikaela Naylon Give Kids a Chance Act, H.R. 1262, Dec. 1. BioWorldRegulatoryU.S.FDALegislation